Loading ...

Stock Quote pard

pard Stock Price Today

pard Price History

pard Stock Price History

pard History

Last Price pard

Close Price pard

Day Change pard

After Hours Quote pard

Open Price pard

Day Range pard

Year Range pard

Projected Yield pard

Market Cap pard

Stock Volume pard

Average Volume pard

Forward Price pard

PE for pard

PB for pard

PS for pard

PCF for pard

price earnings ratio pard

price to book ratio pard

price to sales ratio pard

price to cash flow ratio pard

Stock Quote Poniard Pharmaceuticals Inc

Poniard Pharmaceuticals Inc Stock Price today

Poniard Pharmaceuticals Inc Price history

Poniard Pharmaceuticals Inc Stock Price history

Poniard Pharmaceuticals Inc history

Last Price Poniard Pharmaceuticals Inc

Close Price Poniard Pharmaceuticals Inc

Day Change Poniard Pharmaceuticals Inc

After Hours Quote for Poniard Pharmaceuticals Inc

Open Price Poniard Pharmaceuticals Inc

Day Range Poniard Pharmaceuticals Inc

Year Range Poniard Pharmaceuticals Inc

Projected Yield Poniard Pharmaceuticals Inc

Market Cap Poniard Pharmaceuticals Inc

Stock Volume Poniard Pharmaceuticals Inc

Average Volume Poniard Pharmaceuticals Inc

Forward Price Poniard Pharmaceuticals Inc

pe Poniard Pharmaceuticals Inc

pb Poniard Pharmaceuticals Inc

ps Poniard Pharmaceuticals Inc

pcf Poniard Pharmaceuticals Inc

price earnings ratio Poniard Pharmaceuticals Inc

price to book ratio Poniard Pharmaceuticals Inc

price to sales ratio Poniard Pharmaceuticals Inc

price to cash flow ratio Poniard Pharmaceuticals Inc

What Does This Company Do?
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Distressed
Employees
8
Stock Style
Small Value

Key Stats  PARD More...

Key Stats PARD

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Sponsor Center
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  pard - Poniard Pharmaceuticals Inc More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports pard - Poniard Pharmaceuticals IncMore...

Click above to view more mutual fund data and stats for pard - Poniard Pharmaceuticals Inc.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings
Stock Price Quote: pard Poniard Pharmaceuticals Inc - XOTC - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: 532626 - Pondy Oxides And Chemicals Ltd  |  Next: 532460 - Ponni Sugars (Erode) Ltd